Home Research progress on the mechanism of orexin in pain regulation in different brain regions
Article Open Access

Research progress on the mechanism of orexin in pain regulation in different brain regions

  • Xianhui Kang , Hongli Tang , Yao Liu , Yan Yuan and Mi Wang EMAIL logo
Published/Copyright: January 20, 2021

Abstract

Orexin is a neuropeptide that is primarily synthesized and secreted by the lateral hypothalamus (LH) and includes two substances derived from the same precursor (orexin A [OXA] and orexin B [OXB]). Studies have shown that orexin is not only involved in the regulation of eating, the sleep–wake cycle, and energy metabolism, but also closely associated with various physiological functions, such as cardiovascular control, reproduction, stress, reward, addiction, and the modulation of pain transmission. At present, studies that have been performed both domestically and abroad have confirmed that orexin and its receptors are closely associated with pain regulation. In this article, the research progress on acute pain regulation involving orexin is reviewed.

1 Introduction

Orexins, which are also known as hypocretins, are named according to their strong orexigenic effects and include orexin A (OXA) and orexin B (OXB), both of which are derived from the same precursor protein (pro-orexin). Their receptors are G protein-coupled receptors and include orexin receptor 1 (OX1R) and orexin receptor 2 (OX2R). OXA has almost the same affinity for OX1R and OX2R, whereas OXB has a tenfold higher affinity for OX2R than OX1R [1]. Northern blot analyses of the RNA of adult rats have shown that in the brain, orexins and their receptors are only expressed in the adjacent lateral and posterior regions of the hypothalamus, which are associated with feeding behavior and energy regulation [2]. Although the number of hypothalamic orexin neurons is extremely limited [3], they are able to project to many pain-related brain regions, including the thalamus, limbic system, dorsal raphe nucleus (DR), locus coeruleus (LC), periaqueductal gray (PAG) matter, dorsal hippocampus, reticular formation, and trigeminal caudate nucleus [4]. Numerous studies have shown that in various animal models of inflammatory pain induced by formalin, capsaicin, and carrageenan and in chronic neuropathic pain animal models, the injection of exogenous orexin into the spinal cord and supraspinal sites that are associated with the descending pain regulatory circuits can significantly reduce nociceptive responses. In this article, the current research status of the involvement of orexin in pain regulation in different brain regions is reviewed, with a goal of providing additional references to further clarify the analgesic mechanism of orexin.

2 Spinal cord

The spinal cord is the primary center of pain modulation, and the superficial spinal dorsal horn (DH) (laminae I and II; lamina II is also known as the substantia gelatinosa) is an important site for the transmission and integration of peripheral nociceptive signals [5]. As the principal fibers transmitting mechanical, temperature, and noxious chemical signals from the periphery to the DH, Aδ and C fibers form synapses with DH neurons (especially with spinal glial cells), and these synapses are the key sites for modulating pain signals. Hypothalamic orexin neurons send long-axis projections throughout DH laminae I–II, and OXA content is most abundant in these two laminae [6]. Rezaee et al. [7] have also found that the intrathecal administration of OXA can significantly reduce behavioral responses to thermal and mechanical pain in rats, indicating a potential role of OXA in sensation and pain modulation.

Furthermore, Jeon et al. [6] found that the application of OXA can reduce the amplitude of excitatory postsynaptic currents that are elicited by the electrical stimulation of Aδ or C fibers via the significant inhibition of OX1R-mediated excitatory synaptic transmission [6], which has previously been demonstrated in many animal models of neuropathic pain caused by inflammatory pain and peripheral nerve injury. Subsequently, the same researcher performed a study on long-term depression (LTD) and orexin receptor-mediated DH excitatory synaptic transmission by using the whole-cell patch-clamp technique, and the data showed that OX1R and OX2R antagonists were able to reduce the amplitude of LTD whereas antagonistic effect of OX2R was more significant [8]. This finding indicates that OXA can exert pain modulatory effects at the spinal cord level via different receptors. Studies have also shown that OX2R is densely expressed in the superficial spinal DH in rats [9]. Wang recorded changes in the amplitudes and frequencies of excitatory and inhibitory postsynaptic currents via intrathecal injections of OXB and OXA, as well as via the use of OX1R and OX2R antagonists, in adult rats. The results indicated that OXB can also play a role in modulating pain at the spinal cord level and that the analgesic effects of both OXB and OXA occurred via the activation of OX2R in spinal lamina II [10].

3 PAG matter of the midbrain and dorsal raphe nucleus

The ventrolateral periaqueductal gray (vlPAG) matter of the midbrain is an important site for modulating pain and mood [11] that receives projections from hypothalamic orexin neurons. Studies have shown that after OXA binds to OX1R in the postsynaptic membrane of the vlPAG matter, an endocannabinoid (2-arachidonoylglycerol [2-AG]) is produced via the phospholipase C (PLC)–diacylglycerol lipase (DAGL) pathway [12]. Subsequently, 2-AG acts in a retrograde manner to activate the cannabinoid 1 receptor (CB1R) at the presynaptic membrane, which enables the activation of the vlPAG excitatory neurons that project to the rostral ventromedial medulla (RVM) by inhibiting the abundant GABAergic interneurons in the vlPAG matter. Additionally, the descending pain inhibitory pathway (constituted by the vlPAG-RVM-DH circuit) exerts analgesic effects [13,14]. Studies have shown that injections of OX2R antagonists into the vlPAG matter can block the analgesic effects produced by the injection of carbachol into the lateral hypothalamus (LH) in the tail-flick test, indicating that OX2R in the vlPAG matter is also involved in the modulation of pain and that the analgesic effect of OX2R is not dependent on CB1R [15]. Experiments by Okumura [16] have shown that both CB1R and CB2R antagonists can effectively block the antinociceptive actions of orexin against colonic distention, suggesting that CB2R may also mediate orexin-induced visceral analgesia and that the site of action of CB2R antagonists may be in the brain. However, the specific pathways in which CB2R is involved remain to be further investigated.

The DR, as part of the vlPAG, contains an abundant number of serotonergic neurons and is a vital part of the endogenous pain modulation system. Moreover, we cannot deny the fact that the orexin system is relevant in pain perception, wakefulness, and integration, with its activation linked to circadian periodicity [17]. Antonietta analyzed clinical symptoms and laboratory results in their study and concluded that sleep disorders, such as nocturnal awakenings, insomnia, parasomnias, and food selectivity in autism spectrum disorder (ASD) children can be explained by increased cerebral metabolism and the hyperfunctioning of the autonomic nervous system, which is sustained by high OXA levels [18]. Furthermore, numerous cross-sectional studies have demonstrated a high degree of comorbidity between pain and sleep impairments [19]. Serotonergic neurons, which are well-known as being a central component in migraine attacks, receive an excitatory input from hypothalamic orexin neurons and can reciprocally inhibit orexin neurons through the serotonin 1A receptor. In some cases, multidirectional excitatory connections are present among several brain nuclei (such as PAG and DR), which results in even further complications to the overall mechanism [20]. Researchers have hypothesized that if this system is dysregulated or disrupted, it may facilitate the pathophysiological mechanisms involved in migraines; in addition, the system may simultaneously produce an alteration of the sleep–wake rhythm, thus causing sleep disorders [21].

4 Hippocampus

The hippocampus is not solely a site for regulating emotions, controlling learning and memory, and participating in stress responses; recent studies have shown that the hippocampus is also involved in the regulation of nociception [22]. Partial hippocampal resection has been used for the treatment of chronic pain. Orexinergic fibers project from the LH to the dorsal Cornu Ammonis 1 (CA1) area of the hippocampus, and orexin receptors are distributed in different brain regions associated with memory, including the hippocampus. The injections of OX1R antagonists into the CA1 region of the hippocampus can inhibit the analgesic effect of the LH in a formalin inflammatory pain model in a dose-dependent manner, indicating the existence of a neural pathway from the LH to the CA1 region that modulates pain [23]. Kooshki injected OXA or OX1R antagonists into the CA1 region and observed that the pain responses in capsaicin-treated rats were significantly reduced; furthermore, learning and memory losses were also reduced in these rats [24]. The orexin system is involved in the stress response mediated via the hypothalamic–pituitary axis (HPA). Results from Bahramzadeh et al. [25] revealed that the application of OX1R and OX2R antagonists in the hippocampus can prevent anxiety, immobility, and escape behavior caused by acute stress in rats in the elevated plus maze and in open field tests, indicating that OX1R antagonists can improve the adaptation of rats to stress. However, the specific mechanism of this effect is not yet clear.

5 Rostral ventromedial medulla

The RVM is an important aspect of the descending pain inhibitory system. In the formalin test, microinjections of OXA into the RVM can reduce the pain response, especially in the second phase of formalin-induced inflammatory pain. Furthermore, this analgesic effect can be blocked by a selective OX1R antagonist, indicating that the analgesic effect of OXA is at least partially achieved through OX1R in the RVM [26]. Some researchers have suggested that the first phase of the formalin test is due to the toxic and destructive effects of formalin on the tissues surrounding the injection site and due to the repetitive stimulation of C-fiber nociceptors. In addition, the second phase is due to the central sensitization of the spinal cord caused by the inflammatory response to tissue injury via the release of inflammatory factors and the long-term response of DH neurons to repeated C-fiber inputs [27]. Interestingly, Haghparast observed that the effects of both OX1R and OX2R antagonists were more prominent during the first phase of LH-induced antinociception that occurred during formalin-induced orofacial pain. Therefore, it is speculated that two different nerves are responsible for pain transduction in facial and limb areas [28]. Apart from the descending pain inhibition pathway constituted by the vlPAG-RVM-DH circuit, the question of whether RVM plays a role in other pathways remains to be extensively studied.

6 Locus coeruleus

The LC is an aggregated cluster of noradrenergic neurons in the brainstem, and orexinergic neurons send extensive projections to the LC region; additionally, OX1R is highly expressed in LC neurons. In a formalin experiment, investigators found that microinjections of OXA into the LC can play a role in analgesia, whereas pretreatment with a CB1R antagonist inhibited this effect, thus leading to hyperalgesia [29]. Endorphins are morphine-like transmitters in the central nervous system, and OX1R antagonists in the LC can effectively block the analgesic effects of microinjected endorphins, thus suggesting that the analgesic effects of endorphins in the LC may be mediated by the orexinergic system [30]. Experiments using brain sections of rats with desensitized μ-opioid receptors (MORs) (caused by endorphin exposure) revealed that OXA increased the maximum extent and rate of MOR desensitization and that pretreatment with a protein kinase C inhibitor can significantly inhibit the effect of OXA on the degree of desensitization. However, it had no significant effect on the rate of desensitization, which led to the speculation that OXA affects these two processes via two cellular mechanisms (PKC-dependent and PKC-independent mechanisms) [31]. Abdollahi injected morphine into the LC of rats and used OX1R antagonists to prolong the duration of morphine tolerance in these rats [32]. This led to the speculation, that OXA accelerates the development of morphine tolerance [32]. Based on the previously described studies, it can be speculated that the increased orexin neuronal activity plays an important role in the development of drug-related adverse effects, such as resistance and dependence, during long-term exposure to opioids. Moreover, we cannot neglect to mention that strong excitatory inputs from the lateral paragigantocellularis (LPGi) nuclei have been shown to affect LC neuronal responsiveness during the occurrence of opiate dependence and tolerance [33].

7 Ventral tegmental area (VTA) and nucleus accumbens (NAC)

The VTA comprises a group of neurons in the midbrain or near the midline and is the root of the dopaminergic cell bodies. Orexin can directly stimulate dopaminergic and nondopaminergic neurons via postsynaptic effects. The NAC is a collection of neurons that form the main part of the ventral striatum. Experimenters injected OX1R and OX2R antagonists into the VTA or NAC and found that they could inhibit the analgesic effects of carbachol injected into the LH. Therefore, they speculated that the pathway from the LH to the VTA and NAC plays an important role in pain modulation [34,35]. The study by Azhdari-Zarmehri found that the activation of orexin receptors in the VTA could increase dopamine release via neurons projecting to the NAC [36]. The findings of Okumura et al. indicated that levodopa induces an antinociceptive action against colonic distention by activating D2 dopamine receptors and the orexinergic system in the rat brain [37]. In addition, the results of another study indicated that D1 receptors in the NAC can also mediate the analgesic effect of OXA in the VTA (to some extent) and were involved in the regulation of acute nociceptive responses in rats [38].

8 Conclusion and future directions

Our work attempts to distinguish various brain structures to understand the multifaceted contribution of orexin neurons in endogenous pain regulation (Table 1). Taken together, the evidence indicates that orexin neurons are involved in the regulation of nociception via widespread projections to different parts of the central nervous system. At present, the research of the analgesic effects of orexins is mainly focused on animal experiments, and supporting evidence from clinical trials is mostly related to the treatment of migraines or cluster headaches, with these studies being rare. Studies have suggested that the analgesic effect of OXA is more certain, whereas OXB has a weaker modulatory effect on pain, and the effects of OX1R and OX2R vary greatly in different models. At present, analgesic drugs mainly include opioids and nonsteroidal anti-inflammatory drugs (NSAIDs), with opioids having side effects that include immunosuppression, constipation, nausea, vomiting, and might result in development of addiction caused by long-term use. Although specific cyclooxygenase inhibitors are continuously introduced, NSAIDs present both a slow onset of action and limited analgesic effects and result in adverse reactions in the gastrointestinal tract and in the cardiovascular and nervous systems. To date, orexin preparations have been used in the clinical treatment of sleep disorders, and the in-depth study of the analgesic mechanism of orexin provides a direction for the development of new pain medications. Notably, orexin peptides have been extensively shown to be involved in the regulation of various physiological functions not limited to pain modulation (Figure 1). Therefore, future researchers who are interested in the design of novel drugs that target the orexin system should focus on how these drugs act on specific parts of the brain and on the specific cytoarchitecture and distinct neurochemical characteristics of these drugs, in order for these drugs to reduce adverse reactions.

Table 1

Summary of the studies investigating the role of orexin system in pain and nociception modulation

Regions Methods Endogenous Neuromodulators Receptors Comorbidities Ref.
DH Electrical stimulation of Aδ- or C-primary afferent fibers OrexinA OX1R [6]
Thermal (hot-plate, tail-flick, paw-withdrawal), mechanical (tail-pressure), chemical (formalin, capsaicin, and abdominal stretch) OrexinA, OrexinB ND [7]
Electrical stimulation ND OX1R, OX2R [8]
Patch-clamp whole-cell technique OrexinB OX2R [10]
vlPAG, DRN Patch-clamp whole-cell recording OrexinA OX1R, OX2R, CB1R [12]
Mouse hot-plate test OrexinA OX1R, OX2R, CB1R [13]
Rat tail-flick test ND OX1R, CB1R [14]
Rat tail-flick test ND OX2R [15]
Rat abdominal constriction test OrexinA CB1R, CB2R [16]
Case report ND ND Autism spectrum disorder (ASD) subjects may present a dysregulation in orexinergic neurotransmission [18]
Inference ND ND Sleep-pain coregulation by orexin system [20]
Inference ND Serotonin 1 A receptor In migraine, a dysfunction of orexinergic projections interfering with serotonergic regulation may cause parasomnias [21]
Hippocampus Rat formalin test ND OX1R [23]
Rat intra-lip injection of capsaicin-induced orofacial pain test OrexinA OX1R Learning and memory loss [24]
Rat acute (two mild electric shocks, 5.5 mA) and chronic stresses (10 days of restraint, 6 h daily) ND OX1R, OX2R Impairment of social novelty and anxiety behavior [25]
RVM Rat formalin test OrexinA OX1R [26]
Rat formalin-induced orofacial pain test ND OX1R, OX2R [28]
LC Rat formalin test OrexinA OX1R, CB1R [29]
Rat tail-flick test ND OX1R Analgesic tolerance [30]
Patch-clamp whole-cell recording OrexinA OX1R μ-Opioid receptor desensitization [31]
Vivo extracellular single unit recording ND OX1R Morphine tolerance. [32]
VTA Rat formalin test ND OX2R [34]
Rat tail-flick test ND OX1R, OX2R [35]
Rat abdominal constriction test ND OX1R, D2 dopamine receptor [37]
Rat tail-flick test OrexinA D1/D2 dopamine receptor [38]
Figure 1 
               Efferent projections of orexin/hypocretin neurons, the distribution of orexin receptors, and the associated behavioral functions in postsynaptic target regions. Orexin neurons project widely throughout the brain onto target regions which include the spinal dorsal horn (DH), ventrolateral periaqueductal gray (vlPAG), dorsal raphe (DR), hippocampus, rostral ventromedial medulla (RVM), locus coeruleus (LC), ventral tegmental area (VTA), nucleus accumbens (NAC), the laterodorsal tegmental nucleus and the pedunculopontine tegmental nucleus (LDT/PPT), tuberomammillary nucleus (TMN), hypothalamic paraventricular nucleus (PVN), paraventricular nucleus of the thalamus (PVT), bed nucleus of the stria terminalis (BNST), amygdala, and the medial prefrontal cortex (mPFC). Each of these target regions is involved in the regulation of diverse behavioral and physiological functions.
Figure 1

Efferent projections of orexin/hypocretin neurons, the distribution of orexin receptors, and the associated behavioral functions in postsynaptic target regions. Orexin neurons project widely throughout the brain onto target regions which include the spinal dorsal horn (DH), ventrolateral periaqueductal gray (vlPAG), dorsal raphe (DR), hippocampus, rostral ventromedial medulla (RVM), locus coeruleus (LC), ventral tegmental area (VTA), nucleus accumbens (NAC), the laterodorsal tegmental nucleus and the pedunculopontine tegmental nucleus (LDT/PPT), tuberomammillary nucleus (TMN), hypothalamic paraventricular nucleus (PVN), paraventricular nucleus of the thalamus (PVT), bed nucleus of the stria terminalis (BNST), amygdala, and the medial prefrontal cortex (mPFC). Each of these target regions is involved in the regulation of diverse behavioral and physiological functions.


These authors contributed equally to this work.

tel: +86-15952183267; fax: +86-0516-85806323

Funding

This research was supported by Zhejiang Provincial Natural Science Foundation of China (grant: LY19H310009).

  1. Conflict of interest: The authors state no conflict of interest.

  2. Data availability statement: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

References

[1] Sakurai T. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92:573–85.10.1016/S0092-8674(00)80949-6Search in Google Scholar

[2] Bernardis LL, Bellinger LL. The lateral hypothalamic area revisited: Ingestive behavior. Neurosci Biobehav Rev. 1996;20(2):189–287.10.1016/0149-7634(95)00015-1Search in Google Scholar

[3] Mohammad-Pour Kargar H, Azizi H, Mirnajafi-Zadeh J, Ali Reza M, Semnanian S. Microinjection of orexin-An into the rat locus coeruleus nucleus induces analgesia via cannabinoid type-1 receptors. Brain Res. 2015;1624:424–32.10.1016/j.brainres.2015.07.050Search in Google Scholar

[4] Broberger C, De Lecea L, Sutcliffe JG, Hökfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol. 2015;402(4):460–74.10.1002/(SICI)1096-9861(19981228)402:4<460::AID-CNE3>3.0.CO;2-SSearch in Google Scholar

[5] Dong-Ho Y, Gerber G, Sather WA. Ionotropic glutamate receptors and voltage-gated Ca2+, channels in long-term potentiation of spinal dorsal horn synapses and pain hypersensitivity. Neural Plast. 2013;2013:654257.10.1155/2013/654257Search in Google Scholar

[6] Jeon Y, Park KB, Pervin R, Kim TW, Youn DH. Orexin-A modulates excitatory synaptic transmission and neuronal excitability in the spinal cord substantia gelatinosa. Neurosci Lett. 2015;604:128–33.10.1016/j.neulet.2015.08.001Search in Google Scholar

[7] Rezaee L, Karimi-Haghighi S, Fazli-Tabaei S, Haghparast A. Effects of intrathecal administration of orexin-1 receptor antagonist on antinociceptive responses induced by chemical stimulation of lateral hypothalamus in an animal model of tonic nociception. Neuropeptides. 2018;69:19–25.10.1016/j.npep.2018.03.002Search in Google Scholar

[8] Park KB, Weon H. Orexin receptors mediate long-term depression of excitatory synaptic transmission in the spinal cord dorsal horn. Neurosci Lett. 2017;660:12–16.10.1016/j.neulet.2017.08.068Search in Google Scholar

[9] Cluderay JE, Harrison DC, Hervieu GJ. Protein distribution of the orexin-2 receptor in the rat central nervous system. Regul Pept. 2002;104(1–3):131–44.10.1016/S0167-0115(01)00357-3Search in Google Scholar

[10] Wang C, Fujita T, Kumamoto E. Orexin B modulates spontaneous excitatory and inhibitory transmission in lamina II neurons of adult rat spinal cord. Neuroscience. 2018;383:114–28.10.1016/j.neuroscience.2018.04.048Search in Google Scholar

[11] Pourrahimi AM, Abbasnejad M, Esmaeili-Mahani S, Kooshki R, Raoof M. Intra-periaqueductal gray matter administration of orexin-A exaggerates pulpitis-induced anxiogenic responses and c-fos expression mainly through the interaction with orexin 1 and cannabinoid 1 receptors in rats. Neuropeptides. 2019;73:25–33.10.1016/j.npep.2018.12.001Search in Google Scholar

[12] Ho YC, Lee HJ, Tung LW, Liao YY, Fu SY, Teng SF, Liao HT, Mackie K, Chiou LC. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition. J Neurosci. 2011;31(41):14600–10.10.1523/JNEUROSCI.2671-11.2011Search in Google Scholar PubMed PubMed Central

[13] Lee HJ, Chang LY, Ho YC, Teng SF, Hwang LL, Mackie K, Chiou LC. Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray. Neuropharmacology. 2016;105:577–86.10.1016/j.neuropharm.2016.02.018Search in Google Scholar PubMed PubMed Central

[14] Esmaeili MH, Reisi Z, Ezzatpanah S, Haghparast A. Functional interaction between orexin-1 and CB1 receptors in the periaqueductal gray matter during antinociception induced by chemical stimulation of the lateral hypothalamus in rats. Eur J Pain. 2016;20(10):1753–62.10.1002/ejp.899Search in Google Scholar PubMed

[15] Esmaeili MH, Reisi Z, Ezzatpanah S, Haghparast A. Role of orexin-2 and CB1 receptors within the periaqueductal gray matter in lateral hypothalamic-induced antinociception in rats. Behav Pharmacol. 2017;28(1):83–9.10.1097/FBP.0000000000000277Search in Google Scholar PubMed

[16] Okumura T, Nozu T, Kumei S, Ohhira M. Role of the cannabinoid signaling in the brain orexin- and ghrelin-induced visceral antinociception in conscious rats. J Pharmacol Sci. 2018;137:230–232.10.1016/j.jphs.2018.06.001Search in Google Scholar PubMed

[17] Chieffi S, Carotenuto M, Monda V, Valenzano A, Villano I, Precenzano F, et al. Orexin system: The key for a healthy life. Front Physiol. 2017;8:357.10.3389/fphys.2017.00357Search in Google Scholar PubMed PubMed Central

[18] Messina A, Monda V, Sessa F, Valenzano A, Salerno M, Bitetti I, et al. Sympathetic, metabolic adaptations, and oxidative stress in autism spectrum disorders: How far from physiology? Front Physiol. 2018;9:261.10.3389/fphys.2018.00261Search in Google Scholar PubMed PubMed Central

[19] Herrero Babiloni A, De Koninck B, Beetz G, De Beaumont L, Martel M, Lavigne G. Sleep and pain: Recent insights, mechanisms, and future directions in the investigation of this relationship. J Neural Transm (Vienna). 2020;4:1274–88.10.1007/s00702-019-02067-zSearch in Google Scholar PubMed

[20] Mohammad Ahmadi-Soleimani S, Mianbandi V, Azizi H, Azhdari-Zarmehri H, Ghaemi-Jandabi M, Abbasi-Mazar A, et al. Coregulation of sleep-pain physiological interplay by orexin system: An unprecedented review. Behavioural Brain Res. 2020;391:112650.10.1016/j.bbr.2020.112650Search in Google Scholar PubMed

[21] Messina A, Bitetti I, Precenzano F, Iacono D, Messina G, Roccella M, et al. Non-rapid eye movement sleep parasomnias and migraine: A role of orexinergic projections. Front Neurol. 2018;9:95.10.3389/fneur.2018.00095Search in Google Scholar PubMed PubMed Central

[22] Bahramzadeh ZS, Elahdadi SM, Lashkarbolouki T, Goudarzi I. Hippocampal orexin receptor blocking prevented the stress induced social learning and memory deficits. Neurobiol Learn Mem. 2019;157:12–23.10.1016/j.nlm.2018.11.009Search in Google Scholar PubMed

[23] Pourreza P, Babapour V, Haghparast A. Role of dorsal hippocampal orexin-1 receptors in modulation of antinociception induced by chemical stimulation of the lateral hypothalamus. Physiol Behav. 2018;185:79–86.10.1016/j.physbeh.2017.12.036Search in Google Scholar PubMed

[24] Kooshki R, Abbasnejad M, Esmaeili-Mahani S, Raoof M. The effect of CA1 administration of orexin-A on hippocampal expression of COX-2 and BDNF in a rat model of orofacial pain. Arq Neuropsiquiatr. 2018;76(9):603–8.10.1590/0004-282x20180099Search in Google Scholar

[25] Bahramzadeh ZS, Elahdadi SM, Lashkarbolouki T, Goudarzi L. Hippocampal orexin receptor blocking prevented the stress induced social learning and memory deficits. Neurobiol Learn Mem. 2019;157:12–23.10.1016/j.nlm.2018.11.009Search in Google Scholar

[26] Azhdari-Zarmehri H, Semnanian S, Fathollahi Y. Orexin-A microinjection into the rostral ventromedial medulla causes antinociception on formalin test. Pharmacol Biochem Behav. 2014;122:286–290.10.1016/j.pbb.2014.03.017Search in Google Scholar PubMed

[27] Jahangirvand M, Yazdi F, Moradi M, Haghparast A. Intra-accumbal orexin-1 receptors are involved in antinociception induced by stimulation of the lateral hypothalamus in the formalin test. Iran J Pharm Res. 2016;15(4):851–9.Search in Google Scholar

[28] Haghparast A, Matini T, Rezaee L, Mohammad R, Azita T, Abbas H. Involvement of orexinergic system within the nucleus accumbens in pain modulatory role of the lateral hypothalamus in orofacial pain model. Neurochem Res. 2020;45(4):851–9.10.1007/s11064-020-02957-9Search in Google Scholar PubMed

[29] Mohammad-Pour Kargar H, Azizi H, Mirnajafi-Zadeh J, Ali Reza M, Semnanian S. Microinjection of orexin-an into the rat locus coeruleus nucleus induces analgesia via cannabinoid type-1 receptors. Brain Res. 2015;1624:424–32.10.1016/j.brainres.2015.07.050Search in Google Scholar PubMed

[30] Mohammad Ahmadi-Soleimani S, Azizi H, Mirnajafi-Zadeh J, Semnanian S. Orexin type 1 receptor antagonism in rat locus coeruleus prevents the analgesic effect of intra-LC met-enkephalin microinjection. Pharmacol Biochem Behav. 2015;136:102–6.10.1016/j.pbb.2015.07.010Search in Google Scholar PubMed

[31] Mohammad Ahmadi-Soleimani S, Azizi H, Pachenari N, Mirnajafi-Zadeh J, Semnanian S. Enhancement of μ-opioid receptor desensitization by orexin-A in rat locus coeruleus neurons. Neuropeptides. 2017;63:28–36.10.1016/j.npep.2017.03.004Search in Google Scholar PubMed

[32] Abdollahi H, Ghaemi-Jandabi M, Azizi H, Semnanian S. The role of orexin type-1 receptors in the development of morphine tolerance in locus coeruleus neurons: An electrophysiological perspective. Brain Res. 2016;1646:91–7.10.1016/j.brainres.2016.05.043Search in Google Scholar PubMed

[33] Mohammad Ahmadi-Soleimani S, Azizi H, Gompf H, Semnanian S. Role of orexin type-1 receptors in paragiganto-coerulear modulation of opioid withdrawal and tolerance: A site specific focus. Neuropharmacology. 2017;126:25–37.10.1016/j.neuropharm.2017.08.024Search in Google Scholar PubMed

[34] Yazdi F, Jahangirvand M, Ezzatpanah S, Haghparast A. Role of orexin-2 receptors in the nucleus accumbens in antinociception induced by carbachol stimulation of the lateral hypothalamus in formalin test. Behav Pharmacol. 2016;27(5):431–8.10.1097/FBP.0000000000000216Search in Google Scholar PubMed

[35] Azhdari-Zarmehri H, Reisi Z, Vaziri A, Haghparast A, Shaigani P, Haghparast A. Involvement of orexin-2 receptors in the ventral tegmental area and nucleus accumbens in the antinociception induced by the lateral hypothalamus stimulation in rats. Peptides. 2013;47:94–8.10.1016/j.peptides.2013.07.012Search in Google Scholar PubMed

[36] Azhdari-Zarmehri H, Esmaeili MH, Sofiabadi M, Haghdoost-Yazdi H. Orexin receptor type-1 antagonist SB-334867 decreases morphine-induced antinociceptive effect in formalin test. Pharmacol Biochem Behav. 2013;112:64–70.10.1016/j.pbb.2013.09.018Search in Google Scholar PubMed

[37] Okumura T, Nozu T, Kumei S, Takakusaki K, Miyagishi S, Ohhira M. Levodopa acts centrally to induce an antinociceptive action against colonic distension through activation of D2 dopamine receptors and the orexinergic system in the brain in conscious rats. J Pharmacol Sci. 2016;130(2):123–7.10.1016/j.jphs.2016.01.007Search in Google Scholar PubMed

[38] Yazdi-Ravandi S, Razavi Y, Goudarzvand M, Haghparast A. Orexin A induced antinociception in the ventral tegmental area involves D1 and D2 receptors in the nucleus accumbens. Pharmacol Biochem Behav. 2014;126:1–6.10.1016/j.pbb.2014.08.009Search in Google Scholar PubMed

Received: 2019-12-23
Revised: 2020-09-22
Accepted: 2020-10-04
Published Online: 2021-01-20

© 2021 Xianhui Kang et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Research progress on the mechanism of orexin in pain regulation in different brain regions
  3. Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer
  4. Exogenous spermidine affects polyamine metabolism in the mouse hypothalamus
  5. Iris metastasis of diffuse large B-cell lymphoma misdiagnosed as primary angle-closure glaucoma: A case report and review of the literature
  6. LncRNA PVT1 promotes cervical cancer progression by sponging miR-503 to upregulate ARL2 expression
  7. Two new inflammatory markers related to the CURB-65 score for disease severity in patients with community-acquired pneumonia: The hypersensitive C-reactive protein to albumin ratio and fibrinogen to albumin ratio
  8. Circ_0091579 enhances the malignancy of hepatocellular carcinoma via miR-1287/PDK2 axis
  9. Silencing XIST mitigated lipopolysaccharide (LPS)-induced inflammatory injury in human lung fibroblast WI-38 cells through modulating miR-30b-5p/CCL16 axis and TLR4/NF-κB signaling pathway
  10. Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats
  11. ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
  12. Metabolic profiling of fatty acids in Tripterygium wilfordii multiglucoside- and triptolide-induced liver-injured rats
  13. miR-338-3p inhibits cell growth, invasion, and EMT process in neuroblastoma through targeting MMP-2
  14. Verification of neuroprotective effects of alpha-lipoic acid on chronic neuropathic pain in a chronic constriction injury rat model
  15. Circ_WWC3 overexpression decelerates the progression of osteosarcoma by regulating miR-421/PDE7B axis
  16. Knockdown of TUG1 rescues cardiomyocyte hypertrophy through targeting the miR-497/MEF2C axis
  17. MiR-146b-3p protects against AR42J cell injury in cerulein-induced acute pancreatitis model through targeting Anxa2
  18. miR-299-3p suppresses cell progression and induces apoptosis by downregulating PAX3 in gastric cancer
  19. Diabetes and COVID-19
  20. Discovery of novel potential KIT inhibitors for the treatment of gastrointestinal stromal tumor
  21. TEAD4 is a novel independent predictor of prognosis in LGG patients with IDH mutation
  22. circTLK1 facilitates the proliferation and metastasis of renal cell carcinoma by regulating miR-495-3p/CBL axis
  23. microRNA-9-5p protects liver sinusoidal endothelial cell against oxygen glucose deprivation/reperfusion injury
  24. Long noncoding RNA TUG1 regulates degradation of chondrocyte extracellular matrix via miR-320c/MMP-13 axis in osteoarthritis
  25. Duodenal adenocarcinoma with skin metastasis as initial manifestation: A case report
  26. Effects of Loofah cylindrica extract on learning and memory ability, brain tissue morphology, and immune function of aging mice
  27. Recombinant Bacteroides fragilis enterotoxin-1 (rBFT-1) promotes proliferation of colorectal cancer via CCL3-related molecular pathways
  28. Blocking circ_UBR4 suppressed proliferation, migration, and cell cycle progression of human vascular smooth muscle cells in atherosclerosis
  29. Gene therapy in PIDs, hemoglobin, ocular, neurodegenerative, and hemophilia B disorders
  30. Downregulation of circ_0037655 impedes glioma formation and metastasis via the regulation of miR-1229-3p/ITGB8 axis
  31. Vitamin D deficiency and cardiovascular risk in type 2 diabetes population
  32. Circ_0013359 facilitates the tumorigenicity of melanoma by regulating miR-136-5p/RAB9A axis
  33. Mechanisms of circular RNA circ_0066147 on pancreatic cancer progression
  34. lncRNA myocardial infarction-associated transcript (MIAT) knockdown alleviates LPS-induced chondrocytes inflammatory injury via regulating miR-488-3p/sex determining region Y-related HMG-box 11 (SOX11) axis
  35. Identification of circRNA circ-CSPP1 as a potent driver of colorectal cancer by directly targeting the miR-431/LASP1 axis
  36. Hyperhomocysteinemia exacerbates ischemia-reperfusion injury-induced acute kidney injury by mediating oxidative stress, DNA damage, JNK pathway, and apoptosis
  37. Potential prognostic markers and significant lncRNA–mRNA co-expression pairs in laryngeal squamous cell carcinoma
  38. Gamma irradiation-mediated inactivation of enveloped viruses with conservation of genome integrity: Potential application for SARS-CoV-2 inactivated vaccine development
  39. ADHFE1 is a correlative factor of patient survival in cancer
  40. The association of transcription factor Prox1 with the proliferation, migration, and invasion of lung cancer
  41. Is there a relationship between the prevalence of autoimmune thyroid disease and diabetic kidney disease?
  42. Immunoregulatory function of Dictyophora echinovolvata spore polysaccharides in immunocompromised mice induced by cyclophosphamide
  43. T cell epitopes of SARS-CoV-2 spike protein and conserved surface protein of Plasmodium malariae share sequence homology
  44. Anti-obesity effect and mechanism of mesenchymal stem cells influence on obese mice
  45. Long noncoding RNA HULC contributes to paclitaxel resistance in ovarian cancer via miR-137/ITGB8 axis
  46. Glucocorticoids protect HEI-OC1 cells from tunicamycin-induced cell damage via inhibiting endoplasmic reticulum stress
  47. Prognostic value of the neutrophil-to-lymphocyte ratio in acute organophosphorus pesticide poisoning
  48. Gastroprotective effects of diosgenin against HCl/ethanol-induced gastric mucosal injury through suppression of NF-κβ and myeloperoxidase activities
  49. Silencing of LINC00707 suppresses cell proliferation, migration, and invasion of osteosarcoma cells by modulating miR-338-3p/AHSA1 axis
  50. Successful extracorporeal membrane oxygenation resuscitation of patient with cardiogenic shock induced by phaeochromocytoma crisis mimicking hyperthyroidism: A case report
  51. Effects of miR-185-5p on replication of hepatitis C virus
  52. Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis
  53. Primary localized cutaneous nodular amyloidosis presenting as lymphatic malformation: A case report
  54. Multimodal magnetic resonance imaging analysis in the characteristics of Wilson’s disease: A case report and literature review
  55. Therapeutic potential of anticoagulant therapy in association with cytokine storm inhibition in severe cases of COVID-19: A case report
  56. Neoadjuvant immunotherapy combined with chemotherapy for locally advanced squamous cell lung carcinoma: A case report and literature review
  57. Rufinamide (RUF) suppresses inflammation and maintains the integrity of the blood–brain barrier during kainic acid-induced brain damage
  58. Inhibition of ADAM10 ameliorates doxorubicin-induced cardiac remodeling by suppressing N-cadherin cleavage
  59. Invasive ductal carcinoma and small lymphocytic lymphoma/chronic lymphocytic leukemia manifesting as a collision breast tumor: A case report and literature review
  60. Clonal diversity of the B cell receptor repertoire in patients with coronary in-stent restenosis and type 2 diabetes
  61. CTLA-4 promotes lymphoma progression through tumor stem cell enrichment and immunosuppression
  62. WDR74 promotes proliferation and metastasis in colorectal cancer cells through regulating the Wnt/β-catenin signaling pathway
  63. Down-regulation of IGHG1 enhances Protoporphyrin IX accumulation and inhibits hemin biosynthesis in colorectal cancer by suppressing the MEK-FECH axis
  64. Curcumin suppresses the progression of gastric cancer by regulating circ_0056618/miR-194-5p axis
  65. Scutellarin-induced A549 cell apoptosis depends on activation of the transforming growth factor-β1/smad2/ROS/caspase-3 pathway
  66. lncRNA NEAT1 regulates CYP1A2 and influences steroid-induced necrosis
  67. A two-microRNA signature predicts the progression of male thyroid cancer
  68. Isolation of microglia from retinas of chronic ocular hypertensive rats
  69. Changes of immune cells in patients with hepatocellular carcinoma treated by radiofrequency ablation and hepatectomy, a pilot study
  70. Calcineurin Aβ gene knockdown inhibits transient outward potassium current ion channel remodeling in hypertrophic ventricular myocyte
  71. Aberrant expression of PI3K/AKT signaling is involved in apoptosis resistance of hepatocellular carcinoma
  72. Clinical significance of activated Wnt/β-catenin signaling in apoptosis inhibition of oral cancer
  73. circ_CHFR regulates ox-LDL-mediated cell proliferation, apoptosis, and EndoMT by miR-15a-5p/EGFR axis in human brain microvessel endothelial cells
  74. Resveratrol pretreatment mitigates LPS-induced acute lung injury by regulating conventional dendritic cells’ maturation and function
  75. Ubiquitin-conjugating enzyme E2T promotes tumor stem cell characteristics and migration of cervical cancer cells by regulating the GRP78/FAK pathway
  76. Carriage of HLA-DRB1*11 and 1*12 alleles and risk factors in patients with breast cancer in Burkina Faso
  77. Protective effect of Lactobacillus-containing probiotics on intestinal mucosa of rats experiencing traumatic hemorrhagic shock
  78. Glucocorticoids induce osteonecrosis of the femoral head through the Hippo signaling pathway
  79. Endothelial cell-derived SSAO can increase MLC20 phosphorylation in VSMCs
  80. Downregulation of STOX1 is a novel prognostic biomarker for glioma patients
  81. miR-378a-3p regulates glioma cell chemosensitivity to cisplatin through IGF1R
  82. The molecular mechanisms underlying arecoline-induced cardiac fibrosis in rats
  83. TGF-β1-overexpressing mesenchymal stem cells reciprocally regulate Th17/Treg cells by regulating the expression of IFN-γ
  84. The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia
  85. Red blood cell distribution width-standard deviation but not red blood cell distribution width-coefficient of variation as a potential index for the diagnosis of iron-deficiency anemia in mid-pregnancy women
  86. Small cell neuroendocrine carcinoma expressing alpha fetoprotein in the endometrium
  87. Superoxide dismutase and the sigma1 receptor as key elements of the antioxidant system in human gastrointestinal tract cancers
  88. Molecular characterization and phylogenetic studies of Echinococcus granulosus and Taenia multiceps coenurus cysts in slaughtered sheep in Saudi Arabia
  89. ITGB5 mutation discovered in a Chinese family with blepharophimosis-ptosis-epicanthus inversus syndrome
  90. ACTB and GAPDH appear at multiple SDS-PAGE positions, thus not suitable as reference genes for determining protein loading in techniques like Western blotting
  91. Facilitation of mouse skin-derived precursor growth and yield by optimizing plating density
  92. 3,4-Dihydroxyphenylethanol ameliorates lipopolysaccharide-induced septic cardiac injury in a murine model
  93. Downregulation of PITX2 inhibits the proliferation and migration of liver cancer cells and induces cell apoptosis
  94. Expression of CDK9 in endometrial cancer tissues and its effect on the proliferation of HEC-1B
  95. Novel predictor of the occurrence of DKA in T1DM patients without infection: A combination of neutrophil/lymphocyte ratio and white blood cells
  96. Investigation of molecular regulation mechanism under the pathophysiology of subarachnoid hemorrhage
  97. miR-25-3p protects renal tubular epithelial cells from apoptosis induced by renal IRI by targeting DKK3
  98. Bioengineering and Biotechnology
  99. Green fabrication of Co and Co3O4 nanoparticles and their biomedical applications: A review
  100. Agriculture
  101. Effects of inorganic and organic selenium sources on the growth performance of broilers in China: A meta-analysis
  102. Crop-livestock integration practices, knowledge, and attitudes among smallholder farmers: Hedging against climate change-induced shocks in semi-arid Zimbabwe
  103. Food Science and Nutrition
  104. Effect of food processing on the antioxidant activity of flavones from Polygonatum odoratum (Mill.) Druce
  105. Vitamin D and iodine status was associated with the risk and complication of type 2 diabetes mellitus in China
  106. Diversity of microbiota in Slovak summer ewes’ cheese “Bryndza”
  107. Comparison between voltammetric detection methods for abalone-flavoring liquid
  108. Composition of low-molecular-weight glutenin subunits in common wheat (Triticum aestivum L.) and their effects on the rheological properties of dough
  109. Application of culture, PCR, and PacBio sequencing for determination of microbial composition of milk from subclinical mastitis dairy cows of smallholder farms
  110. Investigating microplastics and potentially toxic elements contamination in canned Tuna, Salmon, and Sardine fishes from Taif markets, KSA
  111. From bench to bar side: Evaluating the red wine storage lesion
  112. Establishment of an iodine model for prevention of iodine-excess-induced thyroid dysfunction in pregnant women
  113. Plant Sciences
  114. Characterization of GMPP from Dendrobium huoshanense yielding GDP-D-mannose
  115. Comparative analysis of the SPL gene family in five Rosaceae species: Fragaria vesca, Malus domestica, Prunus persica, Rubus occidentalis, and Pyrus pyrifolia
  116. Identification of leaf rust resistance genes Lr34 and Lr46 in common wheat (Triticum aestivum L. ssp. aestivum) lines of different origin using multiplex PCR
  117. Investigation of bioactivities of Taxus chinensis, Taxus cuspidata, and Taxus × media by gas chromatography-mass spectrometry
  118. Morphological structures and histochemistry of roots and shoots in Myricaria laxiflora (Tamaricaceae)
  119. Transcriptome analysis of resistance mechanism to potato wart disease
  120. In silico analysis of glycosyltransferase 2 family genes in duckweed (Spirodela polyrhiza) and its role in salt stress tolerance
  121. Comparative study on growth traits and ions regulation of zoysiagrasses under varied salinity treatments
  122. Role of MS1 homolog Ntms1 gene of tobacco infertility
  123. Biological characteristics and fungicide sensitivity of Pyricularia variabilis
  124. In silico/computational analysis of mevalonate pyrophosphate decarboxylase gene families in Campanulids
  125. Identification of novel drought-responsive miRNA regulatory network of drought stress response in common vetch (Vicia sativa)
  126. How photoautotrophy, photomixotrophy, and ventilation affect the stomata and fluorescence emission of pistachios rootstock?
  127. Apoplastic histochemical features of plant root walls that may facilitate ion uptake and retention
  128. Ecology and Environmental Sciences
  129. The impact of sewage sludge on the fungal communities in the rhizosphere and roots of barley and on barley yield
  130. Domestication of wild animals may provide a springboard for rapid variation of coronavirus
  131. Response of benthic invertebrate assemblages to seasonal and habitat condition in the Wewe River, Ashanti region (Ghana)
  132. Molecular record for the first authentication of Isaria cicadae from Vietnam
  133. Twig biomass allocation of Betula platyphylla in different habitats in Wudalianchi Volcano, northeast China
  134. Animal Sciences
  135. Supplementation of probiotics in water beneficial growth performance, carcass traits, immune function, and antioxidant capacity in broiler chickens
  136. Predators of the giant pine scale, Marchalina hellenica (Gennadius 1883; Hemiptera: Marchalinidae), out of its natural range in Turkey
  137. Honey in wound healing: An updated review
  138. NONMMUT140591.1 may serve as a ceRNA to regulate Gata5 in UT-B knockout-induced cardiac conduction block
  139. Radiotherapy for the treatment of pulmonary hydatidosis in sheep
  140. Retraction
  141. Retraction of “Long non-coding RNA TUG1 knockdown hinders the tumorigenesis of multiple myeloma by regulating microRNA-34a-5p/NOTCH1 signaling pathway”
  142. Special Issue on Reuse of Agro-Industrial By-Products
  143. An effect of positional isomerism of benzoic acid derivatives on antibacterial activity against Escherichia coli
  144. Special Issue on Computing and Artificial Techniques for Life Science Applications - Part II
  145. Relationship of Gensini score with retinal vessel diameter and arteriovenous ratio in senile CHD
  146. Effects of different enantiomers of amlodipine on lipid profiles and vasomotor factors in atherosclerotic rabbits
  147. Establishment of the New Zealand white rabbit animal model of fatty keratopathy associated with corneal neovascularization
  148. lncRNA MALAT1/miR-143 axis is a potential biomarker for in-stent restenosis and is involved in the multiplication of vascular smooth muscle cells
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2021-0001/html
Scroll to top button